Susquehanna International Group’s Ibere Pharmaceuticals Units, each consisting of one Class A ordinary share and one-half of one Redeemable Warrant IBER.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$159K Sell
2022
Q3
$175K Sell
2022
Q2
$391K Buy
2022
Q1
$288K Hold
2021
Q4
$294K Hold
2021
Q3
$294K Hold
2021
Q2
$295K Hold
2021
Q1
$290K Buy